Skip to content

Newsroom

The Media Call for journalists on Q2 2024 financial results takes place on July 30, 2024

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

captcha
| Press release
Fresenius Medical Care published form 20-F for the fiscal year 2022
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has filed the annual report 2022 on form 20-F with the U.S. Securities and Exchange Commission (SEC).
| Press release
Fresenius Medical Care places bonds with a volume of 750 million euros
If you are not redirected automatically, click here.
1 ... 3 4 5 ... 26
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.